Request for Information-Long-Term Monitoring of Health Care System Resilience, 34644-34645 [2020-12238]
Download as PDF
<![CDATA[
34644
Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Emergency Awards: Rapid
Investigation of Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS–CoV–2) and
Coronavirus Disease 2019 (COVID–19).
Date: June 22, 2020.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Mohammed S. Aiyegbo,
Ph.D., Scientific Review Officer, AIDS
Research Review Branch, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3E70, Rockville, MD
20852, 301–761–7106, mohammed.aiyegbo@
nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 1, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–12249 Filed 6–4–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Request for Information—Long-Term
Monitoring of Health Care System
Resilience
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Request for Information.
AGENCY:
The Office of the Assistant
Secretary for Health (OASH) in the
Department of Health and Human
Services seeks to gain a more
comprehensive understanding of how
organizations, networks, non-federal
government agencies, and other relevant
stakeholders in the United States have
operationally defined ‘‘resilience’’ in
their respective components of the
health system; including their use of
lotter on DSK9F5VC42PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
21:06 Jun 04, 2020
Jkt 250001
data, analytic approaches and proven
indicators. OASH also seeks to identify
opportunities to strengthen the U.S.
healthcare system, as a whole, through
public-private partnerships in data
sharing and comprehensive analytics.
OASH welcomes any public feedback
related to how these questions should
be addressed and/or potential solutions.
The set of questions is available in the
SUPPLEMENTARY INFORMATION section
below.
DATES: To be assured consideration,
comments must be received at the email
address provided below, no later than
midnight Eastern Time (ET) on July 8,
2020.
ADDRESSES: Individuals are encouraged
to submit responses electronically to
OASHcomments@hhs.gov. Please
indicate ‘‘RFI RESPONSE’’ in the
subject line of your email. Submissions
received after the deadline will not be
reviewed. Responses to this notice are
not offers and cannot be accepted by the
federal government to form a binding
contract or issue a grant. Respond
concisely and in plain language. You
may use any structure or layout that
presents your information well. You
may respond to some or all of our
questions, and you can suggest other
factors or relevant questions. You may
also include links to online material or
interactive presentations. Clearly mark
any proprietary information, and place
it in its own section or file. Your
response will become government
property, and we may publish some of
its non-proprietary content.
FOR FURTHER INFORMATION CONTACT: Dr.
Leith States, Chief Medical Officer,
Office of the Assistant Secretary for
Health (202) 260–2873.
SUPPLEMENTARY INFORMATION:
Background
On January 31st, the U.S. Department
of Health and Human Services (HHS)
declared a public health emergency due
to the outbreak of the 2019 Novel
Coronavirus, now known as COVID–19.
To date, the federal government has
engaged in intensive efforts to prevent
and mitigate the transmission of
COVID–19 within the United States.
These efforts required unprecedented
changes in the functioning of private
businesses, personal lives, the provision
of public services and healthcare. Early
interventions focused primarily on the
redirection of the provision of
healthcare resources towards
individuals with COVID–19 and
mitigation strategies to prevent the
spread of the virus, including markedly
diminished access to health system
services.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Anecdotal reports and experiences
from the frontlines, and emerging data,
indicate that the COVID–19 response
has consequentially resulted in limited
access to routine and emergency
healthcare services in many, if not most,
communities. In regions with significant
burdens of COVID–19 cases, local health
systems have faced challenges with
surge capacity needed to treat COVID–
19 patients. Furthermore, mitigation
strategies to reduce the transmission of
COVID–19 have altered the delivery of
healthcare services across the board,
with many organizations shifting to
providing care via telehealth, reducing
the scale or scope of their healthcare
services or eliminating access,
altogether. Also, human behaviors
around accessing healthcare have been
altered in the midst of recommendations
for social isolation/distancing.
Response to a health crisis, such as
the COVID–19 pandemic, necessitates a
robust public health response and a
highly resilient, adaptable health care
delivery system that can meet the
evolving needs of communities.
Although there is not a common
definition of ‘‘health system resilience’’
(encompassing the provision of direct
clinical care, preventive medicine and
public health activities), the most
referenced definition defines it as ‘‘the
capacity of health actors, institutions,
and populations to prepare for and
effectively respond to crises; maintain
core functions when a crisis hits; and,
informed by lessons learned during the
crisis, reorganize if conditions require
it.’’ 1 Maintaining health system
resilience, particularly during and
following the COVID–19, is a critical
concern in order to ensure the delivery
of high-quality care, from prevention to
high-acuity inpatient care, for all
conditions.
Scope and Assumptions
• The purpose of this Request for
Information (RFI) is to gain a more
comprehensive understanding of how
organizations, networks, non-federal
government agencies, and other relevant
stakeholders in the United States have
operationally defined ‘‘resilience’’ in
their respective components of the
health system; including their use of
data, analytic approaches and proven
indicators. These indicators and data
sets should be able to quantify the
impact of disturbances, such as the
COVID–19 pandemic, on health care
availability, access, timeliness, and
quality.
1 Available at: https://www.thelancet.com/action/
showPdf?pii=S0140-6736%2815%2960755-3.
E:\FR\FM\05JNN1.SGM
05JNN1
Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
• The RFI also seeks to identify
opportunities to strengthen the U.S.
healthcare system, as a whole, through
public-private partnerships in data
sharing and comprehensive analytics.
The RFI seeks to identify organizations
that would be interested in discussing
the form and function of such
collaborations.
• The definition of ‘‘health’’ system
or services and/or ‘‘healthcare’’ system
or services, for the purposes of this RFI,
is in the broadest sense. We seek to
understand resilience implications on
the provision of health services in all
dimensions.
Our Questions
Barrier and Opportunities for Health
System Resilience
1. What have been the most
significant barriers to assessing,
monitoring, and strengthening health
system resilience in the U.S.?
2. What policies and programs can be
improved to mitigate the risk of COVID–
19 and avoid negative impacts on
patient outcomes?
3. What scientific advances are
needed to assess and address
vulnerabilities in the U.S. healthcare
system during the COVID–19 response
and in future disturbances to the
healthcare system?
lotter on DSK9F5VC42PROD with NOTICES
Key Indicators & Data Sources of Health
System Resilience
1. What is your definition of health
system resilience within the context of
your organization? Does the definition
of resilience need to be defined
differently based on geographic region
and/or the domain of healthcare being
assessed?
2. What key indicators or data sets are
being used within your organization to
assess health system resilience?
3. What existing methods, data
sources, and analytic approaches are
being used to assess and monitor health
system resilience in private healthcare
systems?
4. What selected health conditions
should be used as indicators of
healthcare availability, access,
timeliness, and quality, in terms of
treatment and preventive services?
Public/Private Data Sources
1. What data sources does your
organization use to assess the resilience
of the health system? What demographic
populations are covered by these data
systems? Do these data systems capture
urban-rural and other geographic
differences?
2. How are you using these data
sources to inform your public health
response?
VerDate Sep<11>2014
18:21 Jun 04, 2020
Jkt 250001
Public-Private Partnerships
1. Provide ideas of the form and
function of a public-private partnership
model to continually assess and monitor
health system resilience and individual
as well as population health outcomes?
2. What private and public sectors
should HHS engage as part of such a
collaborative effort?
HHS encourages all potentially
interested parties—individuals,
associations, governmental, nongovernmental organizations, academic
institutions, and private sector
entities—to respond. To facilitate
review of the responses, please
reference the question category and
number in your response.
Dated: June 2, 2020.
Paul Reed,
Deputy Assistant Secretary for Health,
Medicine & Science, Office of the Assistant
Secretary for Health.
[FR Doc. 2020–12238 Filed 6–4–20; 8:45 am]
BILLING CODE 4510–28–P
DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
Revision of an Agency Information
Collection Activity Under OMB Review:
Security Appointment Center (SAC)
Visitor Request Form and Foreign
National Vetting Request
Transportation Security
Administration, DHS.
ACTION: 30-Day Notice.
AGENCY:
This notice announces that
the Transportation Security
Administration (TSA) has forwarded the
Information Collection Request (ICR),
Office of Management and Budget
(OMB) control number 1652–0068,
abstracted below to OMB for review and
approval of a revision of the currently
approved collection under the
Paperwork Reduction Act (PRA). The
collection involves gathering
information from individuals who plan
to visit all TSA facilities in the National
Capital Region (NCR). In addition, TSA
is revising the collection to transition
TSA Forms 2802, 2816A, and 2816B
into Common Forms to streamline the
information collection process.
DATES: Send your comments by July 6,
2020. A comment to OMB is most
effective if OMB receives it within 30
days of publication.
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
34645
Affairs, OMB. Comments should be
identified by Docket ID: TSA–2013–
0001 and sent to the Federal
eRulemaking Portal, https://
www.regulations.gov. Please follow the
portal instructions for submitting
comments. This process is conducted in
accordance with 5 CFR 1320.1.
FOR FURTHER INFORMATION CONTACT:
Christina A. Walsh, TSA PRA Officer,
Information Technology (IT), TSA–11,
Transportation Security Administration,
601 South 12th Street, Arlington, VA
20598–6011; telephone (571) 227–2062;
email TSAPRA@tsa.dhs.gov.
SUPPLEMENTARY INFORMATION: TSA
published a Federal Register notice,
with a 60-day comment period soliciting
comments, of the following collection of
information on March 4, 2020, 85 FR
12800.
Comments Invited
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a valid OMB control
number. The ICR documentation will be
available at https://www.reginfo.gov
upon its submission to OMB. Therefore,
in preparation for OMB review and
approval of the following information
collection, TSA is soliciting comments
to—
(1) Evaluate whether the proposed
information requirement is necessary for
the proper performance of the functions
of the agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including using
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Consistent with the requirements of
Executive Order (E.O.) 13771, Reducing
Regulation and Controlling Regulatory
Costs, and E.O. 13777, Enforcing the
Regulatory Reform Agenda, TSA is also
requesting comments on the extent to
which this request for information could
be modified to reduce the burden on
respondents.
Information Collection Requirement
Title: Security Appointment Center
(SAC) Visitor Request Form and Foreign
National Vetting Request.
Type of Request: Revision of a
currently approved collection.
E:\FR\FM\05JNN1.SGM
05JNN1
]]>Agencies
[Federal Register Volume 85, Number 109 (Friday, June 5, 2020)]
[Notices]
[Pages 34644-34645]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-12238]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Request for Information--Long-Term Monitoring of Health Care
System Resilience
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Request for Information.
-----------------------------------------------------------------------
SUMMARY: The Office of the Assistant Secretary for Health (OASH) in the
Department of Health and Human Services seeks to gain a more
comprehensive understanding of how organizations, networks, non-federal
government agencies, and other relevant stakeholders in the United
States have operationally defined ``resilience'' in their respective
components of the health system; including their use of data, analytic
approaches and proven indicators. OASH also seeks to identify
opportunities to strengthen the U.S. healthcare system, as a whole,
through public-private partnerships in data sharing and comprehensive
analytics. OASH welcomes any public feedback related to how these
questions should be addressed and/or potential solutions. The set of
questions is available in the SUPPLEMENTARY INFORMATION section below.
DATES: To be assured consideration, comments must be received at the
email address provided below, no later than midnight Eastern Time (ET)
on July 8, 2020.
ADDRESSES: Individuals are encouraged to submit responses
electronically to [email protected]. Please indicate ``RFI
RESPONSE'' in the subject line of your email. Submissions received
after the deadline will not be reviewed. Responses to this notice are
not offers and cannot be accepted by the federal government to form a
binding contract or issue a grant. Respond concisely and in plain
language. You may use any structure or layout that presents your
information well. You may respond to some or all of our questions, and
you can suggest other factors or relevant questions. You may also
include links to online material or interactive presentations. Clearly
mark any proprietary information, and place it in its own section or
file. Your response will become government property, and we may publish
some of its non-proprietary content.
FOR FURTHER INFORMATION CONTACT: Dr. Leith States, Chief Medical
Officer, Office of the Assistant Secretary for Health (202) 260-2873.
SUPPLEMENTARY INFORMATION:
Background
On January 31st, the U.S. Department of Health and Human Services
(HHS) declared a public health emergency due to the outbreak of the
2019 Novel Coronavirus, now known as COVID-19. To date, the federal
government has engaged in intensive efforts to prevent and mitigate the
transmission of COVID-19 within the United States. These efforts
required unprecedented changes in the functioning of private
businesses, personal lives, the provision of public services and
healthcare. Early interventions focused primarily on the redirection of
the provision of healthcare resources towards individuals with COVID-19
and mitigation strategies to prevent the spread of the virus, including
markedly diminished access to health system services.
Anecdotal reports and experiences from the frontlines, and emerging
data, indicate that the COVID-19 response has consequentially resulted
in limited access to routine and emergency healthcare services in many,
if not most, communities. In regions with significant burdens of COVID-
19 cases, local health systems have faced challenges with surge
capacity needed to treat COVID-19 patients. Furthermore, mitigation
strategies to reduce the transmission of COVID-19 have altered the
delivery of healthcare services across the board, with many
organizations shifting to providing care via telehealth, reducing the
scale or scope of their healthcare services or eliminating access,
altogether. Also, human behaviors around accessing healthcare have been
altered in the midst of recommendations for social isolation/
distancing.
Response to a health crisis, such as the COVID-19 pandemic,
necessitates a robust public health response and a highly resilient,
adaptable health care delivery system that can meet the evolving needs
of communities. Although there is not a common definition of ``health
system resilience'' (encompassing the provision of direct clinical
care, preventive medicine and public health activities), the most
referenced definition defines it as ``the capacity of health actors,
institutions, and populations to prepare for and effectively respond to
crises; maintain core functions when a crisis hits; and, informed by
lessons learned during the crisis, reorganize if conditions require
it.'' \1\ Maintaining health system resilience, particularly during and
following the COVID-19, is a critical concern in order to ensure the
delivery of high-quality care, from prevention to high-acuity inpatient
care, for all conditions.
---------------------------------------------------------------------------
\1\ Available at: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2815%2960755-3.
---------------------------------------------------------------------------
Scope and Assumptions
The purpose of this Request for Information (RFI) is to
gain a more comprehensive understanding of how organizations, networks,
non-federal government agencies, and other relevant stakeholders in the
United States have operationally defined ``resilience'' in their
respective components of the health system; including their use of
data, analytic approaches and proven indicators. These indicators and
data sets should be able to quantify the impact of disturbances, such
as the COVID-19 pandemic, on health care availability, access,
timeliness, and quality.
[[Page 34645]]
The RFI also seeks to identify opportunities to strengthen
the U.S. healthcare system, as a whole, through public-private
partnerships in data sharing and comprehensive analytics. The RFI seeks
to identify organizations that would be interested in discussing the
form and function of such collaborations.
The definition of ``health'' system or services and/or
``healthcare'' system or services, for the purposes of this RFI, is in
the broadest sense. We seek to understand resilience implications on
the provision of health services in all dimensions.
Our Questions
Barrier and Opportunities for Health System Resilience
1. What have been the most significant barriers to assessing,
monitoring, and strengthening health system resilience in the U.S.?
2. What policies and programs can be improved to mitigate the risk
of COVID-19 and avoid negative impacts on patient outcomes?
3. What scientific advances are needed to assess and address
vulnerabilities in the U.S. healthcare system during the COVID-19
response and in future disturbances to the healthcare system?
Key Indicators & Data Sources of Health System Resilience
1. What is your definition of health system resilience within the
context of your organization? Does the definition of resilience need to
be defined differently based on geographic region and/or the domain of
healthcare being assessed?
2. What key indicators or data sets are being used within your
organization to assess health system resilience?
3. What existing methods, data sources, and analytic approaches are
being used to assess and monitor health system resilience in private
healthcare systems?
4. What selected health conditions should be used as indicators of
healthcare availability, access, timeliness, and quality, in terms of
treatment and preventive services?
Public/Private Data Sources
1. What data sources does your organization use to assess the
resilience of the health system? What demographic populations are
covered by these data systems? Do these data systems capture urban-
rural and other geographic differences?
2. How are you using these data sources to inform your public
health response?
Public-Private Partnerships
1. Provide ideas of the form and function of a public-private
partnership model to continually assess and monitor health system
resilience and individual as well as population health outcomes?
2. What private and public sectors should HHS engage as part of
such a collaborative effort?
HHS encourages all potentially interested parties--individuals,
associations, governmental, non-governmental organizations, academic
institutions, and private sector entities--to respond. To facilitate
review of the responses, please reference the question category and
number in your response.
Dated: June 2, 2020.
Paul Reed,
Deputy Assistant Secretary for Health, Medicine & Science, Office of
the Assistant Secretary for Health.
[FR Doc. 2020-12238 Filed 6-4-20; 8:45 am]
BILLING CODE 4510-28-P
